Stanley A Swat,Mardi Gomberg-Maitland
Stanley A Swat
Implantable Cardioverter-Defibrillator Therapy in Contemporary Heart Failure Patients: An Analysis From the EMPEROR-Reduced Trial [0.03%]
当代心力衰竭患者植入式心脏复律除颤器治疗的有效性和安全性：EMPEROR-Reduced研究结果
Mehmet K Aktaş,Khawaja M Talha,Ilan Goldenberg et al.
Mehmet K Aktaş et al.
Background: The benefit of an implantable cardioverter-defibrillator (ICD) in patients with heart failure with reduced ejection fraction on foundational therapy that includes a sodium-glucose cotransporter 2 inhibitor is ...
Sodium-Glucose Cotransporter 2 Inhibitor Following Left Ventricular Assist Device Implantation: A Randomized Controlled Trial [0.03%]
植入左 ventricular assist device 后使用钠-葡萄糖共转运蛋白 2 抑制剂：随机对照试验
Mary E Acosta,Anthony J Kanelidis,Jeremy Slivnick et al.
Mary E Acosta et al.
Noninvasive Wearable-Based Algorithm to Predict Worsening Heart Failure by Change in Natriuretic Peptide Levels [0.03%]
基于穿戴设备的非侵入性算法通过利钠肽水平变化预测心力衰竭恶化
Abhishek Chaturvedi,Savitesh Kushwaha,Uday K Dixit et al.
Abhishek Chaturvedi et al.
Mahwash Kassi,Ashrith Guha
Mahwash Kassi
Impact of Age on Long-Term Clinical Outcomes Following HeartMate 3 LVAD Implantation: Insights From the MOMENTUM 3 Trial [0.03%]
年龄对HeartMate 3型左心室辅助装置植入术后长期临床预后的影响——来自MOMENTUM 3研究的启示
Boaz Elad,Jayant K Raikhelkar,Kevin J Clerkin et al.
Boaz Elad et al.
Background: Age is a key predictor of survival following left ventricular assist device (LVAD) implantation. A detailed understanding of the interaction between age and outcomes can guide strategies for advanced therapies...
Endomyocardial Biopsy-Based Inflammatory Phenotypes Predict Outcomes in Virus-Negative Dilated and Inflammatory Cardiomyopathy [0.03%]
基于内膜心肌活检的炎症表型可以预测病毒阴性的扩张型和炎症性心肌病的预后
Christian Baumeier,Felicitas Escher,Ganna Aleshcheva et al.
Christian Baumeier et al.
Background: Inflammatory cardiomyopathy (CMi) is a major cause of heart failure, but the prognostic significance of different inflammatory phenotypes remains uncertain. Advanced immunohistochemical analyses of endomyocard...
From Hemodynamics to Starling Curves: Applications of Energetic Analysis in Heart Failure Patients [0.03%]
从血流动力学到斯塔令曲线——心力衰竭患者能量分析的应用
Pablo J Blanco,Rohan Goswami,Ryo Torii et al.
Pablo J Blanco et al.
Select Contemporary Statistical Concepts in Heart Failure Clinical Trials: Insights From the Heart Failure Collaboratory [0.03%]
心力衰竭临床试验中的现代统计概念选择：来自心力衰竭协同研究组的见解
Vanessa Blumer,Janet T Wittes,Jordan E Pomeroy et al.
Vanessa Blumer et al.
Evolving statistical concepts and innovative trial designs for heart failure (HF) clinical trials seek to improve the conduct, efficiency, and likelihood of meaningful evidence generation crucial for advancing therapeutic development and op...
Improved Performance of Transthyretin Cardiac Amyloidosis Score by Addition of High-Sensitivity Troponin I: The SCAN-MP Study [0.03%]
高敏型心肌肌钙蛋白I改善了甲状腺转运蛋白心肌淀粉样变性的评分：来自SCAN-MP研究的结果
Nelson I Barrera,Bilal Ansari,Sergio Teruya et al.
Nelson I Barrera et al.